Combination of the STING Agonist MIW815 (ADU-S100) and PD-1 Inhibitor Spartalizumab in Advanced/Metastatic Solid Tumors or Lymphomas: An Open-Label, Multicenter, Phase Ib Study
Meric-Bernstam, Funda, Sweis, Randy F, Kasper, Stefan, Hamid, Omid, Bhatia, Shailender, Dummer, Reinhard, Stradella, Agostina, Long, Georgina V, Spreafico, Anna, Shimizu, Toshio, Steeghs, Neeltje, Luke, Jason J, McWhirter, Sarah M, Müller, Thomas, Nair, Nitya, Lewis, Nancy, Chen, Xinhui, Bean, Andrew, Kattenhorn, Lisa, Pelletier, Marc, Sandhu, Shahneen
Published in Clinical cancer research (04.01.2023)
Published in Clinical cancer research (04.01.2023)
Get full text
Journal Article
Safety and pharmacokinetics of milademetan, a MDM2 inhibitor, in Japanese patients with solid tumors: A phase I study
Takahashi, Shunji, Fujiwara, Yutaka, Nakano, Kenji, Shimizu, Toshio, Tomomatsu, Junichi, Koyama, Takafumi, Ogura, Mariko, Tachibana, Masaya, Kakurai, Yasuyuki, Yamashita, Tomonari, Sakajiri, Sakura, Yamamoto, Noboru
Published in Cancer science (01.06.2021)
Published in Cancer science (01.06.2021)
Get full text
Journal Article
Prevalence of psychological distress, quality of life, and satisfaction among patients and family members following comprehensive genomic profiling testing: Protocol of the Quality of life for Cancer genomics and Advanced Therapeutics (Q-CAT) study
Nishino, Makoto, Fujimori, Maiko, Koyama, Takafumi, Hirata, Makoto, Tanabe, Noriko, Shimizu, Toshio, Yamamoto, Noboru, Uchitomi, Yosuke
Published in PloS one (26.05.2023)
Published in PloS one (26.05.2023)
Get full text
Journal Article
First‐in‐human study of ONO‐4578, an antagonist of prostaglandin E2 receptor 4, alone and with nivolumab in solid tumors
Iwasa, Satoru, Koyama, Takafumi, Nishino, Makoto, Kondo, Shunsuke, Sudo, Kazuki, Yonemori, Kan, Yoshida, Tatsuya, Tamura, Kenji, Shimizu, Toshio, Fujiwara, Yutaka, Kitano, Shigehisa, Shimomura, Akihiko, Sato, Jun, Yokoyama, Fumiharu, Iida, Hiroyuki, Kondo, Maki, Yamamoto, Noboru
Published in Cancer science (01.01.2023)
Published in Cancer science (01.01.2023)
Get full text
Journal Article
Activation of ERBB2 signaling causes resistance to the EGFR-directed therapeutic antibody cetuximab
Yonesaka, Kimio, Zejnullahu, Kreshnik, Okamoto, Isamu, Satoh, Taroh, Cappuzzo, Federico, Souglakos, John, Ercan, Dalia, Rogers, Andrew, Roncalli, Massimo, Takeda, Masayuki, Fujisaka, Yasuhito, Philips, Juliet, Shimizu, Toshio, Maenishi, Osamu, Cho, Yonggon, Sun, Jason, Destro, Annarita, Taira, Koichi, Takeda, Koji, Okabe, Takafumi, Swanson, Jeffrey, Itoh, Hiroyuki, Takada, Minoru, Lifshits, Eugene, Okuno, Kiyotaka, Engelman, Jeffrey A, Shivdasani, Ramesh A, Nishio, Kazuto, Fukuoka, Masahiro, Varella-Garcia, Marileila, Nakagawa, Kazuhiko, Jänne, Pasi A
Published in Science translational medicine (07.09.2011)
Published in Science translational medicine (07.09.2011)
Get more information
Journal Article
Decreased plasma ghrelin in male ALS patients is associated with poor prognosis
Nagaoka, Utako, Shimizu, Toshio, Uchihara, Toshiki, Komori, Takashi, Hosoda, Hiroshi, Takahashi, Kazushi
Published in Neuroscience research (01.04.2022)
Published in Neuroscience research (01.04.2022)
Get full text
Journal Article
Sensory cortex hyperexcitability predicts short survival in amyotrophic lateral sclerosis
Shimizu, Toshio, Bokuda, Kota, Kimura, Hideki, Kamiyama, Tsutomu, Nakayama, Yuki, Kawata, Akihiro, Isozaki, Eiji, Ugawa, Yoshikazu
Published in Neurology (01.05.2018)
Published in Neurology (01.05.2018)
Get more information
Journal Article
Emerging PD-1/PD-L1 targeting immunotherapy in non-small cell lung cancer: Current status and future perspective in Japan, US, EU, and China
Mizuno, Takaaki, Katsuya, Yuki, Sato, Jun, Koyama, Takafumi, Shimizu, Toshio, Yamamoto, Noboru
Published in Frontiers in oncology (26.08.2022)
Published in Frontiers in oncology (26.08.2022)
Get full text
Journal Article
MASTER KEY Project: Powering Clinical Development for Rare Cancers Through a Platform Trial
Okuma, Hitomi S., Yonemori, Kan, Narita, Shoko N., Sukigara, Tamie, Hirakawa, Akihiro, Shimizu, Toshio, Shibata, Taro, Kawai, Akira, Yamamoto, Noboru, Nakamura, Kenichi, Nishida, Toshiro, Fujiwara, Yasuhiro
Published in Clinical pharmacology and therapeutics (01.09.2020)
Published in Clinical pharmacology and therapeutics (01.09.2020)
Get full text
Journal Article
Relationship between EMG-detected and ultrasound-detected fasciculations in amyotrophic lateral sclerosis: A prospective cohort study
Bokuda, Kota, Shimizu, Toshio, Kimura, Hideki, Morishima, Ryo, Kamiyama, Tsutomu, Kawata, Akihiro, Nakayama, Yuki, Isozaki, Eiji
Published in Clinical neurophysiology (01.01.2020)
Published in Clinical neurophysiology (01.01.2020)
Get full text
Journal Article
Enlarged high frequency oscillations of the median nerve somatosensory evoked potential and survival in amyotrophic lateral sclerosis
Norioka, Ryohei, Shimizu, Toshio, Bokuda, Kota, Morishima, Ryo, Kawazoe, Tomoya, Kimura, Hideki, Asano, Yuri, Nakayama, Yuki, Takahashi, Kazushi
Published in Clinical neurophysiology (01.09.2021)
Published in Clinical neurophysiology (01.09.2021)
Get full text
Journal Article
Case report: MRI-negative myelitis following COVID-19 with SEP abnormalities: a case series and literature review
Kawama, Kentaro, Shimazaki, Rui, Sunami, Yoko, Miyakoshi, Natsuki, Tobisawa, Shinsuke, Shimizu, Toshio, Takahashi, Kazushi
Published in Frontiers in neurology (19.10.2023)
Published in Frontiers in neurology (19.10.2023)
Get full text
Journal Article
The difference in the diaphragmatic physiological measures between inspiratory and expiratory phases in ALS
Morishima, Ryo, Shimizu, Toshio, Ishizaka, Yukie, Kimura, Hideki, Bokuda, Kota, Takahashi, Kazushi, Itokawa, Masanari
Published in Neurological sciences (01.12.2022)
Published in Neurological sciences (01.12.2022)
Get full text
Journal Article
Phase I safety and pharmacokinetic study of YM155, a potent selective survivin inhibitor, in combination with erlotinib in patients with EGFR TKI refractory advanced non-small cell lung cancer
Shimizu, Toshio, Nishio, Kazuto, Sakai, Kazuko, Okamoto, Isamu, Okamoto, Kunio, Takeda, Masayuki, Morishita, Maiko, Nakagawa, Kazuhiko
Published in Cancer chemotherapy and pharmacology (01.08.2020)
Published in Cancer chemotherapy and pharmacology (01.08.2020)
Get full text
Journal Article
First‐in‐human phase I study of E7090, a novel selective fibroblast growth factor receptor inhibitor, in patients with advanced solid tumors
Koyama, Takafumi, Shimizu, Toshio, Iwasa, Satoru, Fujiwara, Yutaka, Kondo, Shunsuke, Kitano, Shigehisa, Yonemori, Kan, Shimomura, Akihiko, Iizumi, Sakura, Sasaki, Tatsuya, Furuse, Junji, Yamamoto, Noboru
Published in Cancer science (01.02.2020)
Published in Cancer science (01.02.2020)
Get full text
Journal Article
Comprehensive functional evaluation of variants of fibroblast growth factor receptor genes in cancer
Nakamura, Ikuko Takeda, Kohsaka, Shinji, Ikegami, Masachika, Ikeuchi, Hiroshi, Ueno, Toshihide, Li, Kunhua, Beyett, Tyler S, Koyama, Takafumi, Shimizu, Toshio, Yamamoto, Noboru, Takahashi, Fumiyuki, Takahashi, Kazuhisa, Eck, Michael J, Mano, Hiroyuki
Published in NPJ precision oncology (16.07.2021)
Published in NPJ precision oncology (16.07.2021)
Get full text
Journal Article
A first-in-human, phase 1 study of the NEDD8 activating enzyme E1 inhibitor TAS4464 in patients with advanced solid tumors
Yamamoto, Noboru, Shimizu, Toshio, Yonemori, Kan, Kitano, Shigehisa, Kondo, Shunsuke, Iwasa, Satoru, Koyama, Takafumi, Sudo, Kazuki, Sato, Jun, Tamura, Kenji, Tomomatsu, Junichi, Ono, Makiko, Fukuda, Naoki, Takahashi, Shunji
Published in Investigational new drugs (01.08.2021)
Published in Investigational new drugs (01.08.2021)
Get full text
Journal Article
Effects of oral care on prolonged viral shedding in coronavirus disease 2019 (COVID-19)
Warabi, Yoko, Tobisawa, Shinsuke, Kawazoe, Tomoya, Murayama, Aki, Norioka, Ryohei, Morishima, Ryo, Inoue, Tomoyuki, Shimizu, Toshio, Takahashi, Kazushi
Published in Special Care in Dentistry (01.09.2020)
Published in Special Care in Dentistry (01.09.2020)
Get full text
Journal Article
Web Resource